Comparative Genomics and Proteomics in Drug Discovery

Vol 58
1. Auflage 2006
ISBN: 978-0-415-39653-0
Verlag: Taylor & Francis

Buch, Englisch, 164 Seiten, Format (B × H): 161 mm x 240 mm, Gewicht: 464 g

Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs, and in particular the key role that comparative genomics and proteomics play within this strategy. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.

Zielgruppe

Professional Practice & Development

Autoren/Hrsg.

Parrington, John

Coward, Kevin

Fachgebiete

• Naturwissenschaften Biowissenschaften Botanik Pflanzenreproduktion, Verbreitung, Genetik
• Naturwissenschaften Biowissenschaften Biowissenschaften Genetik und Genomik (nichtmedizinisch)
• Naturwissenschaften Biowissenschaften Tierkunde / Zoologie Tiergenetik, Reproduktion

Inhaltsverzeichnis

1. Comparative Genomics and Drug Discovery in Trypanosomatids 2. The Practical Implications of Comparative Kinetoplastid Genomics 3. The Relevance of Host Genes in Malaria 4. Nicotinic Acetylcholine Receptors as Drug/Chemical Targets, Contributions from Comparative Genomics, Forward and Reverse Genetics 5. Discovery of Novel Sodium Channel Inhibitors - A Gene Family-Based Approach 6. 'Omics' in Translational Medicine: Are They Lost in Translation? 7. Drug-Target Discovery In Silico: Using the Web to Identify Novel Molecular Targets for Drug Action

Über Autor(innen)

John Parrington and Kevin Coward, Department of Pharmacology, University of Oxford, UK.